Cite
HARVARD Citation
Han, Y. et al. (2021). Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study. Thoracic cancer. 12 (2), pp. 145-152. [Online].